- In December 2022, Enovis Corporation announced that they have received the U.S. FDA approval for the STAR PSI System. The STAR PSI System provides a personalized pre-operative plan helps to review a 3D visualization of the patient’s ankle joint, including information about any existing implants and/or bone defects, to plan for the total ankle replacement case. This regulatory approval helped the company to enhance their R&D capabilities and increase their business revenue
- In February 2022, DePuy Synthes a subsidiary of Johnson & Johnson announced the acquisition of CrossRoads Extremity Systems, a manufacturer of foot and ankle devices. This acquisition helped the company to enhance their capabilities in orthopaedic, podiatric and medtech advancements through both internal and external innovation and deliver technologically advanced products
- In March 2016, Xtant Medical Holdings, Inc. entered into a distribution agreement with Vivex Biomedical, Inc. This collaboration introduced OsteoVive, a cellular allograft containing marrow-isolated adult multilineage inducible (MIAMI) cells, designed to support the body's natural bone healing process. Vivex processes the allograft, while Xtant Medical manages its national distribution, focusing on spine and orthopedic applications. This partnership marked Xtant's entry into the rapidly growing cellular bone graft market
- In March 2012, Wright Medical Group, Inc. announced a supply and distribution agreement with AlloSource for FUSIONFLEX Bone Matrix, a flexible cancellous scaffold designed for primary fusion procedures in the foot and ankle, as well as other orthopedic bone grafting applications. The FUSIONFLEX graft serves as a carrier and matrix for new bone repair, offering surgeons intraoperative flexibility to graft prepared fusion sites, provide carrying capacity for bone marrow aspirate, and create a matrix that conforms intimately to the fusion site
- In May 2023, Paragon 28 introduced its Gorilla Supramalleolar Osteotomy (SMO) Plating and PRESERVE SMO Allograft System. This system offers surgeons versatile options for plate selection and surgical approaches in supramalleolar osteotomies. It includes patent-pending drilling and cutting guides for controlled anterior dome, medial opening, and closing wedge osteotomies, along with an allograft cutting jig to shape the PRESERVE™ SMO Allograft Wedge, aiming to reduce procedure time and complexity
Frequently Asked Questions
The increase in rising preference for minimally invasive procedures using foot and ankle allografts, is emerging as a pivotal trend driving the Europe foot and ankle allografts market.
The major factors driving the growth of the Europe foot and ankle allografts market are growing need due to rising cases of foot and ankle trauma due to sports such as football, basketball, and running are increasing the demand for surgical interventions using allografts
The primary challenges include high cost of sourcing, processing, and storing foot and ankle allografts contributes to elevated procedure expenses compared to traditional surgical options
The orthopaedic reconstruction segment is expected to dominate the Europe foot and ankle allografts market with the largest share of 34.05% in 2025 due to the increasing prevalence of foot and ankle disorders that require reconstructive surgeries.
